Xenon Pharmaceuticals develops investigational drugs for neurological and psychiatric conditions, led by azetukalner for epilepsy and depression. It last closed at $37.04 on Nov 20, down 1.38% on the day. The next earnings report for XENE is expected around Thu, Feb 25, 2027, after the close. For the quarter ended Sep 2026, XENE reported EPS of -$1.11 on revenue of $0. Over its last 8 reports the stock moved an average of 5.0% the session after earnings. Over the last 12 months XENE insiders bought $1.7M of stock on the open market and sold $22.0M, according to SEC Form 4 filings.
AI Auto Pilots
Is XENE in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold XENE.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on XENEStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
XENE · as of the Nov 20 close · updated each morning
Downtrend
The stock is 4% below its 20 day and 5% below its 50 day average. It is 41% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 41). The nearest support is the Pivot S1 at $36.57, and the nearest resistance the Pivot at $37.27.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 4.1%/day
Key levels
$72.6652 week high+96.2%
$52.20200 day average+40.9%
$51.24100 day average+38.3%
$39.92Swing high (Oct 1)+7.8%
$39.0250 day average+5.3%
$38.5420 day average+4.0%
$37.74Pivot R1+1.9%
$37.27Pivot+0.6%
$37.04Last close
$36.57Pivot S1−1.3%
$36.07Swing low (Sep 23)−2.6%
$33.3852 week low−9.9%
Indicators
RSI (14)
41.11
Middle of its range
Neutral
MACD
-0.25
Below its signal line
Bearish
Stochastic
12.3
Near the bottom of its range
Oversold
ADX (14)
20.8
Weak trend
Williams %R
-94.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-58.9
Oversold below −100, overbought above 100
Neutral
Rate of change
−5.4%
Change over 10 sessions
Bearish
ATR (14)
$1.51
Typical daily range, 4.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 12.3%/day
Key levels
$72.6652 week high+96.2%
$52.20200 day average+40.9%
$51.24100 day average+38.3%
$39.92Swing high (Oct 1)+7.8%
$39.0250 day average+5.3%
$38.5420 day average+4.0%
$37.74Pivot R1+1.9%
$37.27Pivot+0.6%
$37.04Last close
$36.57Pivot S1−1.3%
$36.07Swing low (Sep 23)−2.6%
$33.3852 week low−9.9%
Indicators
RSI (14)
35.31
Weak, oversold below 30
Neutral
MACD
-4.85
Below its signal line
Bearish
Stochastic
17.0
Near the bottom of its range
Oversold
ADX (14)
33.9
Trending down
Williams %R
-88.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-67.2
Oversold below −100, overbought above 100
Neutral
Rate of change
−36.9%
Change over 10 sessions
Bearish
ATR (14)
$4.54
Typical daily range, 12.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for XENE
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how XENE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow XENE usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for XENEHow many large options trades hit XENE, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in XENE in the last 90 days.
From SEC Form 4 filings by XENE's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether XENE is in one of them and how their past XENE trades turned out.
Xenon Pharmaceuticals is a biopharmaceutical company based in Burnaby, Canada, that focuses on drugs for neurological and psychiatric conditions. Its lead investigational medicine, azetukalner, is in late-stage trials for epilepsy, major depressive disorder and bipolar depression. The company also has earlier-stage programs aimed at pain and other conditions. Its intended customers are patients with these disorders, and it may commercialize its candidates alone or with partners.